Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Healthcare Bioconvergence Companies

ID: MRFR/HC/10078-HCR
128 Pages
Vikita Thakur
Last Updated: May 15, 2026
"Healthcare bioconvergence" is a term that may not be widely associated with specific companies or a well-defined industry sector. However, the concept of bioconvergence generally refers to the convergence of various disciplines within the life sciences and healthcare sectors.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Healthcare Bioconvergence Market

Healthcare Bioconvergence Key Companies
 
Latest Healthcare Bioconvergence Companies Update:

BiomX (microbiome therapeutics) Received a Therapeutics Development Award of up to $5 million from the Cystic Fibrosis Foundation to develop phage therapies for cystic fibrosis.

Century Therapeutics (cell therapy) Collaborated with Bristol Myers Squibb to commercialize IPSC-derived allogenic cell-based therapies, strengthening their position in personalized medicine.

Abu Dhabi Department of Health and Israel Innovation Authority Partnered to work on critical health innovation projects, including proof-of-concept and clinical trials.

Life Arc (UK medical research firm) Funded $5.74 million for the Gen OMICC COVID-19 project, supporting patient enrollment, sample collection, and bioinformatics analysis.

List of Healthcare Bioconvergence Key companies in the market
  • Ginkgo Bioworks (US)
  • Thermo Fisher Scientific Inc. (US)
  • GE Healthcare (US)
  • Siemens (Germany)
  • BiomX (Israel)
  • Century Therapeutics (US)
  • Singota Solutions (US)
  • Galvani Bioelectronics (UK)
  • Bico Group (US)
  • SetPoint Medical (US)